Mesoblast (MEOBF) Total Current Liabilities (2014 - 2026)

Mesoblast has disclosed Total Current Liabilities across 13 years of filings, most recently posting $81.1 million for Q2 2026.

• In Q2 2026, Total Current Liabilities fell 20.96% year-over-year to $81.1 million; the TTM figure through Jun 2026 stood at $81.1 million (down 20.96% YoY), while the FY2026 annual figure was $81.1 million, down 20.96% from the prior year.
• Total Current Liabilities came in at $81.1 million for Q2 2026 at Mesoblast, down from $128.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $128.1 million in Q4 2025 to a low of $31.4 million in Q4 2023.
• Average Total Current Liabilities over 5 years is $66.0 million, with a median of $54.2 million recorded in 2022.
• Year-over-year, Total Current Liabilities tumbled 47.47% in 2022 and soared 131.93% in 2024.
• Over 5 years, Total Current Liabilities stood at $54.6 million in 2022, then slumped by 42.53% to $31.4 million in 2023, then soared by 131.93% to $72.8 million in 2024, then soared by 76.04% to $128.1 million in 2025, then slumped by 36.67% to $81.1 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $81.1 million in Q2 2026, $128.1 million in Q4 2025, and $102.6 million in Q2 2025.